mutLBSgeneDB |
Gene summary for PAX3 |
Gene summary |
Basic gene Info. | Gene symbol | PAX3 |
Gene name | paired box 3 | |
Synonyms | CDHS|HUP2|WS1|WS3 | |
Cytomap | UCSC genome browser: 2q35 | |
Type of gene | protein-coding | |
RefGenes | NM_000438.5, NM_001127366.2,NM_013942.4,NM_181457.3,NM_181458.3, NM_181459.3,NM_181460.3,NM_181461.3, | |
Description | paired box homeotic gene 3paired box protein Pax-3paired domain gene 3paired domain gene HuP2 | |
Modification date | 20141222 | |
dbXrefs | MIM : 606597 | |
HGNC : HGNC | ||
Ensembl : ENSG00000135903 | ||
HPRD : 09421 | ||
Vega : OTTHUMG00000133157 | ||
Protein | UniProt: P23760 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_PAX3 | |
BioGPS: 5077 | ||
Pathway | NCI Pathway Interaction Database: PAX3 | |
KEGG: PAX3 | ||
REACTOME: PAX3 | ||
Pathway Commons: PAX3 | ||
Context | iHOP: PAX3 | |
ligand binding site mutation search in PubMed: PAX3 | ||
UCL Cancer Institute: PAX3 | ||
Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0045893 | positive regulation of transcription, DNA-templated | 11863357 | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 11863357 |
Top |
Ligand binding site mutations for PAX3 |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | N269 | N269S | COAD | 1 | R271 | R271H | COAD | 1 | R262 | R262Q | COAD | 1 | Y243 | D245E | GBM | 1 | R271,N269 | R270H | LAML | 1 | Y243 | D245Y | LUAD | 1 | R271,N269 | R270S | LUAD | 1 | R273 | W274L | LUSC | 1 | R220 | R220H | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for PAX3 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | N269 | N269S | 0.092970266 | R273 | W274L | 0.071656318 | R262 | R262Q | -1.4326718 | R271 | R270S | -1.2462788 | N269 | R270S | -1.2462788 | R271 | R270H | -1.151034 | N269 | R270H | -1.151034 | R271 | R271H | -1.1415456 | R220 | R220H | -0.98976221 | Y243 | D245Y | -0.34817167 | Y243 | D245E | -0.32234723 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for PAX3 from PDB |
Top |
Differential gene expression and gene-gene network for PAX3 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for PAX3 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0206655 | Rhabdomyosarcoma, Alveolar | 97 | Biomarker, GeneticVariation |
umls:C3266898 | Waardenburg Syndrome | 44 | Biomarker, GeneticVariation |
umls:C1847800 | Waardenburg Syndrome Type 1 | 33 | Biomarker, GeneticVariation |
umls:C0080178 | Spinal Dysraphism | 10 | Biomarker, GeneticVariation |
umls:C1261473 | Sarcoma | 8 | Biomarker |
umls:C0079661 | Klein-Waardenburg syndrome | 4 | Biomarker, GeneticVariation |
umls:C1852510 | Craniofacial deafness hand syndrome | 3 | Biomarker, GeneticVariation |
umls:C0027794 | Neural Tube Defects | 3 | AlteredExpression, Biomarker, Therapeutic |
umls:C0376634 | Craniofacial Abnormalities | 1 | Biomarker |
umls:C0011053 | Deafness | 1 | Biomarker |
umls:C0018566 | Hand Deformities, Congenital | 1 | Biomarker |
umls:C0497552 | Nervous System Malformations | 1 | Biomarker |
umls:C1710096 | Sinonasal undifferentiated carcinoma | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for PAX3 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of PAX3 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
Top |
Conservation information for LBS of PAX3 |
Multiple alignments for P23760 in multiple species |
LBS | AA sequence | # species | Species | F226 | RSRTTFTAEQL | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | N269 | QVWFSNRRARW | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | R217 | DLPLKRKQRRS | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | R220 | LKRKQRRSRTT | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | R221 | KRKQRRSRTTF | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | R223 | KQRRSRTTFTA | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | R262 | KLTEARVQVWF | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | R271 | WFSNRRARWRK | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | R273 | SNRRARWRKQA | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | S222 | RKQRRSRTTFT | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | S268 | VQVWFSNRRAR | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | T224 | QRRSRTTFTAE | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | V265 | EARVQVWFSNR | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | W266 | ARVQVWFSNRR | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus | Y243 | FERTHYPDIYT | 3 | Homo sapiens, Xenopus tropicalis, Mus musculus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |